ACRS
Aclaris Therapeutics, Inc. · Healthcare
Director Andrew N Schiff sold $700K of Aclaris Therapeutics, Inc.
Sold$700,355
$17.01Price
41,174Shares
−8%Stake
What ACRS did after the filing
- The stock from Wed, Oct 26 close, $16.48
- −5.9%
- S&P 500, same days
- +3.7%
Measured over 30 trading days, to the Dec 8 close.
Traded Mon, Oct 24. Filed Wed, Oct 26, 3:09 PM ET, during the session. Returns use the Oct 26 close and the Dec 8 close. Not investment advice.